# A Study to See How Safe a New Medicine (NNC0705-0001) is in Healthy People

> **NCT07029568** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 116 (actual)

## Conditions studied

- Healthy Volunteers
- Chronic Kidney Disease

## Interventions

- **DRUG:** NNC0705-0001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07029568
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-13
- **Primary completion:** 2025-11-04
- **Final completion:** 2025-12-10
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07029568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07029568, "A Study to See How Safe a New Medicine (NNC0705-0001) is in Healthy People". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07029568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*